⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 1, 2026Journal of College of Physicians And Surgeons PakistanOpen Access

Impact of Types of Cytoreductive Surgery on Survival and Morbidity in Recurrent Epithelial Ovarian Cancer

Akbar Ibrahımov

View Full Paper

Ask AI

Bookmark

Share

Key Points

To assess how different types of cytoreductive surgery affect survival rates and morbidity in patients with recurrent epithelial ovarian cancer.
Observational study focusing on survival and morbidity rates
Comparison of various types of cytoreductive surgery
Evaluation of patient outcomes post-surgery
Cytoreductive surgery impacts overall survival in recurrent ovarian cancer patients
Different surgical approaches lead to varying levels of morbidity
Survival outcomes differ significantly based on type of surgery performed

Implication

Observational research highlights varied survival outcomes in recurrent ovarian cancer, suggesting surgical approaches influence patient morbidity.

Abstract

Tertiary cytoreduction, Ovarian cancer recurrence, Surgical oncology, Survival outcomes, Peritoneal carcinomatosis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Akbar Ibrahımov (2026) studied this question.

synapsesocial.com/papers/6992652ceb1f82dc367a113f https://doi.org/10.29271/jcpsp.2026.02.163

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-AnalysisMeta-Analysis · 2023 · 10 citations
2The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis2024 · 2 citations
3Secondary cytoreduction in recurrent ovarian cancer- experience from a tertiary care centre in India2024 · 1 citations
4Primary Cytoreduction and Survival for Patients With Less-Common Epithelial Ovarian Cancer2024 · 7 citations
5Role of secondary cytoreduction in relapsed ovarian cancer2024 · 1 citations